United Therapeutics
UTHR
$272.69
Share price
1.08%
Change (1 day)
27.19%
Change (1 year)
Categories
United Therapeutics (UTHR) - Total assets
Total assets on the balance sheet as of March 2024 : $6.49 B
According to United Therapeutics's latest financial reports the company's total assets are $6.49 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
United Therapeutics - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $7.16 B | 18.57% |
| 2022-12-31 | $6.04 B | 16.94% |
| 2021-12-31 | $5.16 B | 12.01% |
| 2020-12-31 | $4.61 B | 17.93% |
| 2019-12-31 | $3.91 B | 15.07% |
| 2018-12-31 | $3.40 B | 18.11% |
| 2017-12-31 | $2.87 B | 23.81% |
| 2016-12-31 | $2.32 B | 6.46% |
| 2015-12-31 | $2.18 B | 15.92% |
| 2014-12-31 | $1.88 B | -9.73% |
| 2013-12-31 | $2.08 B | 28.34% |
| 2012-12-31 | $1.62 B | 7.15% |
| 2011-12-31 | $1.51 B | 6.04% |
| 2010-12-31 | $1.43 B | 36.15% |
| 2009-12-31 | $1.05 B | 20.24% |
| 2008-12-31 | $0.87 B | 48.98% |
| 2007-12-31 | $0.58 B | 23.07% |
| 2006-12-31 | $0.47 B | 63.68% |
| 2005-12-31 | $0.29 B | 40.67% |
| 2004-12-31 | $0.20 B | 15.41% |
| 2003-12-31 | $0.17 B | -2.74% |
| 2002-12-31 | $0.18 B | -12.99% |
| 2001-12-31 | $0.21 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $226.50 B | 3,387.21% | 🇺🇸 USA |
 Eli Lilly LLY | $63.94 B | 884.47% | 🇺🇸 USA |
 Baxter BAX | $27.78 B | 327.82% | 🇺🇸 USA |
 Gilead Sciences GILD | $62.12 B | 856.48% | 🇺🇸 USA |
 Cardinal Health CAH | $45.88 B | 606.37% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $73.94 B | 1,038.41% | 🇬🇧 UK |
 Cytokinetics
CYTK | $0.82 B | -87.31% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 569.40% | 🇮🇱 Israel |